ADMET & DMPK (ISSN 1848-7718) is an international, peer reviewed open-access Journal aiming for rapid dissemination of orginal research articles, review papers and comments in the broad areas of absorption, distribution, metabolism, excretion, toxicology and pharmacokinetics of drugs. The emphasis is on rapid publishing of articles of high scientific quality and make them freely available to researchers worldwide.



Editor-in-chief: Kin Tam


Associate Editor (Oncology): Godefridus J. Peters


Editorial Board

Imprint information

ISSN 1848-7718





3rd World Conference on ADMET and DMPK

Zagreb, Croatia, September, 04-06, 2017






: Special issue: Role of drug transporters in drug development: a qualitative and quantitative approach

Guest Editors: Abdul Naveed Shaik, Sumit Basu  
Posted: 1970-01-01 More...
More Announcements...

Vol 5, No 1 (2017)

Table of Contents


Tyrosine kinase inhibitors: new molecules in non-small cell lung cancer (EGFR AND ALK) PDF
Fernando Franco, Miriam Mendez, Lourdes Gutierrez, Mariano Provencio 1-8
Biomembrane mimics and their roles in anti-bacterial drug discovery PDF
Xiaohui Hu, Kin Tam 9-13

Original Scientific Articles

In vitro membrane binding and protein binding (IAM MB/PB technology) to estimate in vivo distribution: applications in early drug discovery PDF
Klara Livia Valko, Simon P. Teague, Charles Pidgeon 14-38
Biorelevant dissolution of candesartan cilexetil PDF
Lucie Gruberová, Bohumil Kratochvil 39-46
The inhibition of adenylate kinase by 2,4-thiazolidinedione evaluated by protein-ligand docking PDF
Mihaela Ileana Ionescu 47-56

ISSN 1848-7718